A novel pyridopyrimidine inhibitor of abl kinase is a picomolar inhibitor of Bcr-abl-driven K562 cells and is effective against STI571-resistant Bcr-abl mutants. (Q40595462)
Jump to navigation
Jump to search
scientific article published on April 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A novel pyridopyrimidine inhibitor of abl kinase is a picomolar inhibitor of Bcr-abl-driven K562 cells and is effective against STI571-resistant Bcr-abl mutants. |
scientific article published on April 2003 |
Statements
A novel pyridopyrimidine inhibitor of abl kinase is a picomolar inhibitor of Bcr-abl-driven K562 cells and is effective against STI571-resistant Bcr-abl mutants (English)
David R Huron
Mercedes E Gorre
Alan J Kraker
Charles L Sawyers
Neal Rosen
Mark M Moasser